

Sequence of application of prothrombin complex concentrate and blood coagulation factors in obstetric bleedings (clinical cases)
Heading: Anaesthesiology and Reanimatology Article type: Case report
Authors: Kuligin A.V., Lushnikov A.V., Arzhaeva I.A., Shchukovsky N.V., Guryanov A.M., Morozov I.A., Zeulina Е.Е.
Organization: Saratov State Medical University
Currently, in the intensive care of coagulopathy, as a clinical manifestation of massive obstetric bleeding, plasma and recombinant concentrates of factors of the blood coagulation system are used with good effect, which include, respectively, the concentrate of the prothrombin complex "Prothromplex 600" and the recombinant factor (rFVIIa) "Coagil-VII". When regulating the interaction of drugs, the simultaneous administration of the prothrombin complex concentrate and rFVIIa is not recommended, due to the lack of knowledge of the interaction of these categories of drugs (as well as with antifibrinolytics), while in the instructions for the use of the prothrombin complex concentrate there are no direct indications of the undesirability of using it with rFVIIa. The cases cited by the authors of the sequential use of prothrombin complex concentrate and rFVIIa confirm the presence of clear indications for their use, as well as the possibility of consistent use in compliance with the requirements of dynamic laboratory monitoring in women with massive obstetric bleeding caused by an abnormal location of the placenta and amniotic fluid embolism.
Bibliography:
1. Kuligin AV, Lushnikov AV, Zeulina ЕЕ, Prodanova EV. Transfusiological support for massive obstetric bleeding: a guide. Saratov: Publishing Center of Saratov State Medical University, 2020; 136 p.
2. Kuligin AV, Lushnikov AV, Zeulina ЕЕ. Anesthesiological allowance for high-risk operations of massive obstetric blood loss: a guide. Saratov: Publishing Center of Saratov State Medical University, 2021; 148 p.
3. Yun X, Peijie Н, Jiang D, et al. Massive obstetric hemorrhage in maternal near miss in ICU: a retrospective analysis from a maternity center in Shanghai, China. Int J Clin Exp Med 2018; 11 (9): 9638-45.
4. Gillissen A, van den Akker T, Caram-Deelder C, et al. Coagulation parameters during the course of severe postpartum hemorrhage: a nationwide retrospective cohort study. Blood Adv 2018; 2 (19): 2433-42.
5. Filippov O.S., Guseva E.V., Malyshkina A.I. Maternal mortality in the Russian Federation in 2016. Methodical Letter of the Ministry of Health of the Russian Federation dated 23/10/2017 № 15-4/10/2-7339. In: Kulikov AV, Shifman EM, eds. Anesthesia, intensive care and resuscitation in obstetrics and gynecology. Clinical recommendations. Treatment protocols. Moscow: Medicine, 2018; p. 6-101.
6. Practice Guidelines for Perioperative Blood Management. An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management/The American Society of Anesthesiologists Committee on Standards and Practice Parameters and the Task Force on Perioperative Blood Management Anesthesiology. Anesthesiology 2015; 122 (2): 241-75.
7. Shifman EM, Kulikov AV, Protsenko DN. Anesthesia and intensive therapy for massive blood loss in obstetrics. Clinical guidelines (protocol). In: Kulikov AV, Shifman EM, eds. Anesthesia, intensive care and resuscitation in obstetrics and gynecology. Clinical recommendations. Treatment protocols. Moscow: Medicine, 2018; p. 152-98.
8. Afshan В, Hameed MD, Christine НМ. California Maternal Quality Care Collaborative (CMQCC). Cardiovascular Disease in Pregnancy and Postpartum Toolkit. 2017; 134 p.
9. Kulikov AV, Shiftman EM, Bulanov AYu, et al. Intensive therapy of acute disorders of hemostasis in obstetrics (DIC syndrome). Clinical guidelines (Treatment protocols). In: Kulikov AV, Shifman EM, eds. Anesthesia, intensive care and resuscitation in obstetrics and gynecology. Clinical guidelines. Treatment protocols. Moscow: Medicine, 2017; 462-89.
10. Practice Bulletin №183: Postpartum Hemorrhage Committee on Practice Bulletins Obstetrics. Obstet Gynecol 2017; 130(4): 168-86.
11. WHO Reproductive Health Library. WHO recommendation on tranexamic acid for treatment of postpartum haemorrhage. Geneva: World Health Organization, 2017; 41 p.
12. Collins P, CollisR. Management of obstetric hemorrhage: Hemostatic management. In: Pavord S, Hunt B, eds. The obstetric hematology manual. Cambridge: Cambridge University Press, 2018; p. 217-26.
13. Shaylor R, Weininger CF, Austin N. National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative. Anesth Analg 2017; 124 (1): 216-32.
14. Adamyan LV, Artymuk NV, Barinov SV. Embolism with amniotic fluid: intensive therapy and obstetric tactics. Clinical guidelines (protocol) approved Ministry of Health of the Russian Federation 10/20/2017 № 15-4/10/2-7317. In: Kulikov AV, Shifman EM, eds. Anesthesia, intensive care and resuscitation in obstetrics and gynecology. Clinical recommendations. Treatment protocols. Moscow: Medicine, 2018; p. 238-69.
Attachment | Size |
---|---|
2022_2_215-222.pdf | 341.02 KB |